EDINBURG, (Texas) -DHR Health and DHR Health Institute for Research and Development has partnered with other hospitals in the region to establish a protocol to treat life-threatening COVID-19 patients using plasma from donors.
According to a news release from DHR, the plasma will be coming from donors who have recovered from COVID-19 infection.
“It has been previously documented that plasma from patients who have recovered from COVID-19 infections contains antibodies that may help fight the disease” says the release.
DHR Health and other hospital in the regions have partnered with Vitalant, an FDA-approved blood donation center with facilities in McAllen and Harlingen to collect plasma from identified donors.
The release says this protocol has been reviewed and approved by the DHR Health Institute for Research and Development, Institutional Review Board to ensure compliance with federal and state regulations involving human research subjects.
“This is a unique opportunity for individuals who have recovered from COVID-19 infection to help patients who are suffering from severe or life-threatening COVID-19”
The release says the small plasma sample will also be used for research studies that will help improve our current understanding of the virus. DOnors will be provided with a modest financial stipend to participate in the study.
If you qualify to be a potential donor, please contact DHR at 956-215-3166, 956 342-4896.
Or email them at firstname.lastname@example.org
For more information visit their website.